AMT Stock Recent News

The Federal Reserve's rate cuts should benefit the real estate market. Lower interest rates mean lower mortgage costs for buyers and an added incentive to sell for homeowners not eager to trade in a low-rate mortgage for a higher one.

Solid demand for AMT's wireless communication assets by network carriers and expansion efforts bode well. However, customer concentration is a major woe.

LEXINGTON, Mass. and AMSTERDAM, Sept. 23, 2024 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to AMT-191, uniQure's investigational gene therapy for the treatment of Fabry disease, a rare, inherited genetic disease. In August 2024, uniQure announced the dosing of the first patient in its U.S., multi-center, open-label Phase I/IIa trial of AMT-191.

The relative resistance zone sits right around 240.

American Tower is no longer a growth story; FFO has flatlined over the past three years despite inflationary tailwinds. Valuation compression was close to being done when we last wrote about it, but the big rally and poor FFO growth have changed things drastically. The stock is now at a Sell rating.

American Tower's (AMT) stock price appreciated by nearly 24% since February, driven by improved financial performance and a more dovish-looking Fed. The India exit, involving a $2.5 billion asset sale, impacts AMT's global ranking and revenue but aids in deleveraging and improving FFO per share. Despite challenges in 5G investment globally, AMT expects U.S. market growth and has seen increased application activity, beating Q1 and Q2 expectations.

Sarat Sethi, DCLA portfolio manager, joins 'Squawk Box' to discuss his top stock picks.

AMT announces the completion of the sale of its India operations to Brookfield. Proceeds from the sale are to be used to repay its existing debt.

American Tower Corporation (NYSE:AMT ) Goldman Sachs Communacopia + Technology Conference September 9, 2024 4:45 PM ET Company Participants Steve Vondran - Chief Executive Officer Conference Call Participants Jim Schneider - Goldman Sachs Jim Schneider Okay, great. Hey, good morning, everybody, or good afternoon, everybody.

U.S. equity markets posted their worst week since March 2023 while benchmark interest rates tumbled to eighteen-month lows after employment data indicated a further cooling in economic momentum. Among several disappointing reports, BLS Nonfarm Payrolls data showed that the U.S. economy added just 142k jobs in August, while prior months were again revised sharply lower. Snapping a four-week winning streak that lifted the major benchmark to the cusp of record highs, the S&P 500 tumbled 4.1% this week. Technology stocks dragged on the downside.